A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity - 30/11/11
Doi : 10.1016/j.jaci.2011.07.001
Taco W. Kuijpers, MD, PhD a 
, Paul A. Baars, PhD b, Daan J. aan de Kerk, MD a, b, Machiel H. Jansen a, b, Ingrid A.M. Derks b, Robbert G.M. Bredius, MD, PhD d, Elisabeth A.M. Sanders, MD, PhD e, Mirjam van der Burg, MD, PhD f, Marielle Alders, MD, PhD c, Rene A.W. van Lier, MD, PhD b, 
, Paul A. Baars, PhD b, Daan J. aan de Kerk, MD a, b, Machiel H. Jansen a, b, Ingrid A.M. Derks b, Robbert G.M. Bredius, MD, PhD d, Elisabeth A.M. Sanders, MD, PhD e, Mirjam van der Burg, MD, PhD f, Marielle Alders, MD, PhD c, Rene A.W. van Lier, MD, PhD b, a Emma Children’s Hospital, Academic Medical Center, Amsterdam, The Netherlands
b Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands
c Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands
d Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands
e Wilhelmina Children’s Hospital, University Medical Center, Utrecht, The Netherlands
f Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 128 - N° 6
P. 1360 - décembre 2011 Regresar al número
Artículo precedente
- Predisposition to the development of IL-9–secreting T cells in atopic infants
- Weiguo Yao, Robert S. Tepper, Mark H. Kaplan
- Anaphylaxis to apple and orange seed
- Paul J. Turner, Paul E.A. Gray, Melanie Wong, Nirupama Varese, Jennifer M. Rolland, Robyn O’Hehir, Dianne E. Campbell
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?